(Total Views: 398)
Posted On: 10/13/2018 12:59:30 PM
Post# of 32696
Let me start off with saying I don’t believe we will need a RS, and RS was never talked about except to say no RS, obviously things can change, and RS into strength (great news and partners) wouldn’t be bad in order to get on Nasdaq, where many investors and institutions want in. The devoted shareholders would not budge, maybe even buy more. On Nasdaq nothing will stop us when we start rolling in money and news.
I was in AVXL when they did a RS to uplist, the price went up quickly on Nasdaq, then it was heavily shorted, and it had three or four days in a row that more shares were traded than the company had outstanding. Now AVXL is nothing like FUSZ, they are a biotech company without a product they are selling but have products being tested.
Even though AVXL is different I feel as though a similar thing could happen if FUSZ does a RS without substantial PRs prior or after
I was in AVXL when they did a RS to uplist, the price went up quickly on Nasdaq, then it was heavily shorted, and it had three or four days in a row that more shares were traded than the company had outstanding. Now AVXL is nothing like FUSZ, they are a biotech company without a product they are selling but have products being tested.
Even though AVXL is different I feel as though a similar thing could happen if FUSZ does a RS without substantial PRs prior or after
(6)
(0)Scroll down for more posts ▼
